Pathophysiology and Classification of Cirrhosis
Cirrhosis develops through progressive stages of liver damage. Widespread fibrosis, nodule formation, and loss of normal hepatic architecture gradually destroy liver function.
The pathophysiologic progression involves three key steps: chronic inflammation, hepatocyte necrosis, and myofibroblast activation. These processes deposit excessive collagen in liver tissue.
This fibrotic remodeling increases intrahepatic resistance and leads to portal hypertension. Portal hypertension then cascades into multiple systemic complications.
Classification by Etiology
Circhosis is classified into two main types based on cause:
- Alcoholic cirrhosis (most common in developed countries) from chronic alcohol consumption
- Non-alcoholic cirrhosis from viral hepatitis, autoimmune liver disease, biliary obstruction, or metabolic disorders like hemochromatosis and Wilson disease
Child-Pugh Classification System
This system grades cirrhosis severity using five parameters: total bilirubin, serum albumin, prothrombin time, ascites, and hepatic encephalopathy. Scores range from 5-15.
Class A (5-6 points) indicates mild disease with excellent survival. Class C (13-15 points) indicates severe disease with significantly reduced survival prospects.
MELD Score for Prognosis
The Model for End-Stage Liver Disease score combines INR, creatinine, and bilirubin levels. It predicts short-term mortality and prioritizes liver transplant allocation.
Understanding these classification systems helps you anticipate complications. You can tailor care intensity and treatment approaches accordingly.
Major Complications and Clinical Manifestations
Cirrhosis precipitates multiple life-threatening complications requiring vigilant assessment and intervention. Portal hypertension (pressure greater than 12 mmHg) develops from increased intrahepatic resistance and triggers the most serious complications.
Variceal Bleeding
Portal hypertension causes esophageal, gastric, or rectal varices to form. These vessels can rupture suddenly, causing hematemesis, melena, or hematochezia.
Recognize early warning signs including tachycardia, hypotension, and anxiety. Prepare patients for sclerotherapy or band ligation procedures immediately.
Hepatic Encephalopathy
This condition results from ammonia and nitrogenous waste accumulating when the liver cannot metabolize them. Mental status changes range from subtle confusion to complete coma.
Common precipitating factors include:
- Increased protein intake
- Constipation
- Infection or bleeding
- Diuretics or NSAIDs
Prevention through lactulose administration and dietary management is essential.
Spontaneous Bacterial Peritonitis (SBP)
Bacteria translocate across the intestinal barrier in patients with ascites. SBP causes fever, abdominal pain, and peritoneal inflammation requiring antibiotics.
Hepatorenal Syndrome
This represents functional kidney failure despite structurally normal kidneys. Progressive oliguria and elevated creatinine develop. Mortality exceeds 50 percent without liver transplantation.
Other Critical Complications
Coagulopathy from decreased hepatic clotting factor synthesis creates spontaneous bleeding risk. Ascites accumulation from portal hypertension and sodium retention causes abdominal distension and respiratory compromise.
Nursing priorities include fluid restriction, diuretic management, SBP monitoring, paracentesis assessment, and nutritional support.
Nursing Assessment and Diagnostic Evaluation
Comprehensive nursing assessment requires systematic evaluation of hepatic function, portal hypertension effects, and multisystem complications.
Physical Examination Findings
Key assessment findings provide critical diagnostic clues:
- Jaundice from hyperbilirubinemia
- Spider angiomas and palmar erythema from impaired estrogen metabolism
- Ascites from portal hypertension and low albumin
- Asterixis (flapping tremor) from hepatic encephalopathy
Abdominal assessment must evaluate for hepatomegaly or a shrunken fibrotic liver. Assess for splenomegaly from portal hypertension and fluid wave or shifting dullness indicating ascites.
Assess mental status carefully. Document baseline cognition and alertness because subtle changes may indicate early encephalopathy.
Laboratory Evaluation
Lab tests focus on liver synthetic function and cholestasis markers:
- Prothrombin time and albumin show synthetic function
- Bilirubin and alkaline phosphatase reveal cholestasis
- Complete metabolic panel identifies electrolyte abnormalities like hyponatremia and hypokalemia
- Platelet count falls from splenic sequestration
- Ammonia levels may correlate with encephalopathy severity
Imaging and Diagnostic Studies
Ultrasound with Doppler assesses liver echotexture, portal vein patency, and ascites volume. Endoscopy directly visualizes esophageal and gastric varices. Transient elastography measures liver stiffness correlating with fibrosis stage.
Understand how these findings integrate to guide treatment. They help you monitor disease progression and anticipate complications.
Nursing Interventions and Treatment Management
Evidence-based interventions target complication prevention, symptom management, and preparation for potential transplantation.
Nutritional Management
Careful nutritional balance is critical. High-quality protein with branched-chain amino acids is preferred over restriction to maintain lean body mass.
Caloric intake should meet 1.2 to 1.5 times basal metabolic requirements. Restrict sodium to 2 grams daily. Fluid restriction to one liter daily is typical if hyponatremia develops.
Encephalopathy Prevention
Administer lactulose to achieve two to three bowel movements daily. This reduces colonic ammonia absorption. Rifaxomicin may be added for additional bacterial reduction.
Ascites Management
Diuretics including spironolactone and furosemide manage ascites effectively. Monitor renal function and electrolytes carefully because rapid diuresis risks prerenal azotemia.
Paracentesis removes ascitic fluid when respiratory compromise occurs or diagnostic evaluation is needed.
Portal Pressure Reduction
Beta-blockers including propranolol or carvedilol reduce portal pressure and prevent variceal bleeding through splanchnic vasodilation. Band ligation and sclerotherapy manage active variceal hemorrhage.
Proton pump inhibitors reduce gastric acid and bleeding risk. Low-molecular-weight heparin may be considered for portal vein thrombosis if it develops.
Monitoring and Prevention
Monitor vital signs, intake and output, weight trends, and mental status regularly. Strict infection prevention through handwashing and vaccination against hepatitis A and B is critical.
Recognize spontaneous bacterial peritonitis early. Provide patient education addressing alcohol cessation, medication compliance, dietary adherence, and warning signs.
Liver Transplantation Considerations and Quality of Life
Liver transplantation offers the only curative treatment for end-stage cirrhosis. Organ allocation and recipient selection are critical nursing considerations.
Transplant Candidacy and Evaluation
Transplant evaluation assesses medical stability, absence of contraindications like active infection or untreated malignancy, and likelihood of graft success. The MELD score prioritizes patients based on predicted mortality risk.
Living donor transplantation from relatives offers potential advantages of reduced wait time and better outcomes compared to deceased donor grafts.
Pre and Post-Transplant Nursing
Pre-transplant nursing includes psychosocial assessment, education about surgery and lifelong immunosuppression, optimization of nutritional status, and coordination with the transplant team.
Post-transplant management focuses on monitoring for rejection through liver function tests, preventing infection during immunosuppression, and managing medication side effects from tacrolimus or cyclosporine.
Quality of Life for Non-Transplant Candidates
For patients not transplant candidates or awaiting transplantation, quality of life optimization becomes the primary goal.
Address specific symptoms:
- Fatigue through rest periods and activity pacing
- Pruritus through emollients and medications
- Abdominal discomfort from ascites through positioning and diuretics
Provide psychological support addressing anxiety, depression, and body image concerns related to ascites and jaundice.
Palliative Care Planning
Palliative care becomes appropriate for patients with decompensated cirrhosis and poor prognosis. Focus on comfort, dignity, and family support.
Facilitate advance care planning discussions. Ensure patients' values and preferences guide all care decisions. Connect patients with community resources including support groups, financial assistance programs, and home health services.
